Business
Scope Fluidics Extends Collaboration For FDA Certification
Scope Fluidics Extends Collaboration For FDA Certification
About this update from Scope Fluidics Sa
Scope Fluidics SA GPW:SCP:EXTENDS COLLABORATION FOR FDA CERTIFICATION FOR BACTEROMIC SYSTEM WITH UNI FAST PANELTHANKS TO EXPANSION OF COOPERATION, BACTEROMIC WILL BE ABLE TO APPLY FOR FDA CERTIFICATION IMMEDIATELY FOR THE BACTEROMIC SYSTEM WITH UNI FAST PANELBACTEROMIC TO ASSESS UP TO 52 ANTIBIOTICS AND 3 RESISTANCE MECHANISMSCLINICAL STUDY COSTS INCREASE TO $3.3 MILLION FROM $2.0 MILLION DUE TO EXTENSIONFDA CERTIFICATION EXPECTED IN FIRST HALF OF 2027